Radiology & Solvents Manufacturing Cluster

Radiology & Solvents Manufacturing Cluster

Exciting News from our Bergkamen manufacturing site:

Our new #DynamicSharedOwnership operating model is changing the way we work and is putting patients and products at the center of our doing.?

To best possibly support our patients and their healthcare practitioners (HCPs) in the field of radiology, on October 1st, we are launching our new API-manufacturing cluster Radiology & Solvents here at our Bergkamen manufacturing site. In this cluster, we are bringing together our dedicated API manufacturing plant for X-ray/CT and MRI contrast media with our highly flexible and efficient solvent recovery plant.

Our core mission is reliable supply of the growing demands in contrast media. To succeed on this challenge, an efficient and sustainable supply of liquid raw materials with high solvent recovery rates and a growing portfolio of recycled solvents is essential.

Together with my team, we are creating an agile, lean and efficient organization and strive for impactful outcomes with respect to costs, sustainability and most importantly supply security. In line with #DynamicSharedOwnership we will invest in our people to enable all of us to best possibly contribute on our mission “Health for all” and unleash our full potential.

#DynamicSharedOwnership #Sustanability #HealthForAll #TeamBayer

Dr. Sujenth Kirupakaran , Daniel Loehr, Fatih Alp, Roy Herrmann , Andreas Jelonek, Michaela Suenskes, Jan Scheffczyk , Meike Kaune, Steffen Wahl , Fabian Lehmhaus , Marco Lenkenhoff







Dear Julian, I wish you and your team a great start! This huge and complex cluster comes with great responsibility, you have all my respect taking it! Best, Ilona

回复
Dr. Ralf Wischnat

| Certified Coach | Pharma and R&D Operations | Target Operating Model | Change & Transformation | People Growth & Development |

5 个月

Dear Julian, I wish you personally and your entire great team all the best, success and lots of fun for the upcoming journey Cheers Ralf

要查看或添加评论,请登录

社区洞察

其他会员也浏览了